Wellington, HBM lead €22m round for Adrenomed
Wellington Partners and HBM Healthcare Investments have led a €22m financing round for Germany-based biopharmaceutical company Adrenomed.
Wellington Partners and HBM Healthcare Investments have led a €22m financing round for Germany-based biopharmaceutical company Adrenomed.
Liberta Partners has acquired a majority stake in Switzerland-based medical devices producer Forteq Healthcare in a carve-out from Forteq Group.
Firm operates hospitals, clinics and medical centres across Poland
Private equity firm Abris Capital Partners has fully acquired Polish clinics operator Scanmed from Life Healthcare Group Holdings for PLN 340m.
Where EcoR1 stands to profit from healthy deal making From Institutional Investor: These are busy times for the folks at Oleg Nodelman s EcoR1 Capital, an investment firm focused on therapeutic companies in the biotechnology
Silverfleet Capital has scored a 3.1x return selling its majority stake in 7days, a German supplier of workwear for the healthcare industry, to fellow private equity firms Chequers Capital and Paragon Partners.
Abris Capital Partners has agreed a buyout of Polish healthcare network operator Scanmed from Life Healthcare Group.
Apeiron Investment Group, angel investor Peter Thiel, and Catalio Capital Management have led a $125m series-C round for Germany-based psychedelic and non-psychedelic mental health therapy compounds developer Atai Life Sciences.
Each year, as part of our Women to Watch honorees’ feature, we also highlight the accomplishments of a handful of women at the midpoint of their careers. This year’s class spans industries that include software,
Transatlantic biotech investor SR One has raised its first fund in the wake of spinning out from pharmaceutical giant GlaxoSmithKline.
Telecoms giant Orange has agreed to back LBO France's Digital Health 2 fund, which plans to invest €200m in e-health SMEs in France and Western Europe.
Mercia Asset Management-backed coronavirus antibody company Abingdon Health has filed for an initial public offering.
Healthcare-focused Ampersand Capital Partners has raised $670m for a continuation vehicle to buy up a trio of portfolio businesses from its mature private equity funds.
